Pathologic Characteristics of Early or Late Acute Cellular Rejection and Outcome After Kidney Transplant

被引:7
作者
Wu, Kaiyin [1 ]
Budde, Klemens [1 ]
Schmidt, Danilo [1 ]
Neumayer, Hans-Helmut [1 ]
Rudolph, Birgit [2 ]
机构
[1] Charite, Med Klin Schwerpunkt Nephrol, D-10117 Berlin, Germany
[2] Charite, Inst Pathol, D-10117 Berlin, Germany
关键词
Graft biopsy; End-stage renal disease; Interstitial fibrosis and tubular atrophy; Graft survival; Interstitial inflammation; Vascular disorders; RENAL-ALLOGRAFT REJECTION; WORKING CLASSIFICATION; VASCULAR REJECTION; HLA ANTIBODIES; RECENT ERA; BIOPSIES; IMPACT; DIAGNOSIS; SURVIVAL; EPISODES;
D O I
10.6002/ect.2014.0044
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: To determine the pathologic features of early- and late-onset acute cellular rejection that may contribute to graft loss after kidney transplant. Materials and Methods: There were 247 patients who had acute cellular rejection included in the study. The biopsy that showed the highest acute cellular rejection severity was evaluated for each patient (total, 247 biopsies) and classified as early (time of biopsy, <= 6 mo) or late (time of biopsy, > 6 mo) acute cellular rejection. Results: The mean scores of interstitial inflammation (interstitial inflammation and tubulitis), scarring (interstitial fibrosis/tubular atrophy), and vascular disorders (arteriolar hyaline thickening and vascular intimal fibrosis) were significantly higher in late than early acute cellular rejection. Death-censored graft survival at 8 years after kidney transplant was higher in patients who had early (88%) than late acute cellular rejection (66%; P <= .001). Early and late acute cellular rejection with either low- or high-grade interstitial fibrosis/tubular atrophy had similar death-censored graft survival. In patients who had late acute cellular rejection, death-censored graft survival was significantly higher when there was low- (survival; 79%) than high-grade vascular intimal fibrosis (survival, 48%; P <= .006). Long-term graft loss was significantly associated with the number of biopsies, intimal arteritis, and tubulitis in patients who had early acute cellular rejection, and vascular intimal fibrosis in patients who had late acute cellular rejection. Conclusions: High-grade vascular intimal fibrosis was a risk factor for poor long-term graft survival in late acute cellular rejection after kidney transplant.
引用
收藏
页码:314 / 322
页数:9
相关论文
共 32 条
  • [1] Predicting subsequent decline in kidney allograft function from early surveillance biopsies
    Cosio, FG
    Grande, JP
    Wadei, H
    Larson, TS
    Griffin, MD
    Stegall, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2464 - 2472
  • [2] Renal allograft biopsies with borderline changes: Predictive factors of clinical outcome
    Dahan, K.
    Audard, V.
    Roudot-Thoraval, F.
    Desvaux, D.
    Abtahi, M.
    Mansour, H.
    Kumal, M.
    Lang, P.
    Grimbert, P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (07) : 1725 - 1730
  • [3] Role of non-HLA antibodies in organ transplantation
    Dragun, Duska
    Philippe, Aurelie
    Catar, Rusan
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (04) : 440 - 445
  • [4] Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
    Einecke, G.
    Sis, B.
    Reeve, J.
    Mengel, M.
    Campbell, P. M.
    Hidalgo, L. G.
    Kaplan, B.
    Halloran, P. F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (11) : 2520 - 2531
  • [5] Identifying Specific Causes of Kidney Allograft Loss
    El-Zoghby, Z. M.
    Stegall, M. D.
    Lager, D. J.
    Kremers, W. K.
    Amer, H.
    Gloor, J. M.
    Cosio, F. G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (03) : 527 - 535
  • [6] Correlation between Banff classification, acute renal rejection scores and reversal of rejection
    Gaber, LW
    Moore, LW
    Alloway, RR
    Flax, SD
    ShokouhAmiri, MH
    Schroder, T
    Gaber, AO
    [J]. KIDNEY INTERNATIONAL, 1996, 49 (02) : 481 - 487
  • [7] Immunosuppressive drugs for kidney transplantation
    Halloran, PF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) : 2715 - 2729
  • [8] Hillebrands Jan-Luuk, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S146239940300557X
  • [9] Identification and Therapeutic Management of Highly Sensitized Patients Undergoing Renal Transplantation
    Huber, Lu
    Lachmann, Nils
    Duerr, Michael
    Liefeldt, Lutz
    Neumayer, Hans-H.
    Schoenemann, Constanze
    Budde, Klemens
    [J]. DRUGS, 2012, 72 (10) : 1335 - 1354
  • [10] Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients
    Irish, WD
    Mccollum, DA
    Tesi, RJ
    Owen, AB
    Brennan, DC
    Bailly, JE
    Schnitzler, MA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11): : 2967 - 2974